gamma-aminobutyric acid has been researched along with Myofascial Pain Syndromes in 2 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Myofascial Pain Syndromes: Muscular pain in numerous body regions that can be reproduced by pressure on TRIGGER POINTS, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of gabapentin on pain scores and opiate use." | 9.08 | The effect of gabapentin on neuropathic pain. ( de Rosayro, AM; Harrell, C; Ristic, H; Rosenberg, JM; Werner, RA, 1997) |
| " A significant decrease in pain scores with gabapentin was seen in the neuropathic pain group (paired t-test, p < ." | 9.08 | The effect of gabapentin on neuropathic pain. ( de Rosayro, AM; Harrell, C; Ristic, H; Rosenberg, JM; Werner, RA, 1997) |
| "Gabapentin may be a useful adjunct for treating neuropathic pain with a minimum of side effects." | 9.08 | The effect of gabapentin on neuropathic pain. ( de Rosayro, AM; Harrell, C; Ristic, H; Rosenberg, JM; Werner, RA, 1997) |
| "To evaluate the effects of gabapentin on pain scores and opiate use." | 5.08 | The effect of gabapentin on neuropathic pain. ( de Rosayro, AM; Harrell, C; Ristic, H; Rosenberg, JM; Werner, RA, 1997) |
| " A significant decrease in pain scores with gabapentin was seen in the neuropathic pain group (paired t-test, p < ." | 5.08 | The effect of gabapentin on neuropathic pain. ( de Rosayro, AM; Harrell, C; Ristic, H; Rosenberg, JM; Werner, RA, 1997) |
| "Gabapentin may be a useful adjunct for treating neuropathic pain with a minimum of side effects." | 5.08 | The effect of gabapentin on neuropathic pain. ( de Rosayro, AM; Harrell, C; Ristic, H; Rosenberg, JM; Werner, RA, 1997) |
| " This study underscores our previous findings that eToims is safe and efficacious for long-term use in CRMP." | 1.43 | Chronic refractory myofascial pain and denervation supersensitivity as global public health disease. ( Bruyninckx, F; Chu, J; Neuhauser, DV, 2016) |
| "Low back pain has a 9." | 1.43 | Chronic refractory myofascial pain and denervation supersensitivity as global public health disease. ( Bruyninckx, F; Chu, J; Neuhauser, DV, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, J | 1 |
| Bruyninckx, F | 1 |
| Neuhauser, DV | 1 |
| Rosenberg, JM | 1 |
| Harrell, C | 1 |
| Ristic, H | 1 |
| Werner, RA | 1 |
| de Rosayro, AM | 1 |
1 trial available for gamma-aminobutyric acid and Myofascial Pain Syndromes
| Article | Year |
|---|---|
The effect of gabapentin on neuropathic pain.
Topics: Acetates; Adolescent; Adult; Amines; Analgesics; Child; Cyclohexanecarboxylic Acids; Gabapentin; gam | 1997 |
1 other study available for gamma-aminobutyric acid and Myofascial Pain Syndromes
| Article | Year |
|---|---|
Chronic refractory myofascial pain and denervation supersensitivity as global public health disease.
Topics: Amines; Analgesics; Chronic Pain; Cyclohexanecarboxylic Acids; Denervation; Electric Stimulation The | 2016 |